How should traders position for PDEX's upcoming Q3 earnings?

**Pro-Dex Inc. (PDEX) is poised for a positive outlook in its upcoming Q3 earnings report**, and traders should consider the following points when positioning themselves: 1. **Expected Growth**: Analysts have recently upgraded their forecasts for Pro-Dex's 2025 earnings, with revenue expected to reach $68 million and EPS to increase to $2.30. This reflects a bullish sentiment and suggests that Q3 could see continued growth momentum. 2. **Historical Performance**: Pro-Dex has demonstrated strong performance in recent quarters, with revenue and earnings surpassing expectations in both Q2 2025 and Q1 2025. This track record indicates a high likelihood of positive results in Q3. 3. **Market Position**: Pro-Dex's niche in the medical device industry, particularly in powered surgical instruments, positions it well for potential growth as the global healthcare market expands. The company's innovative products and consulting services are likely to contribute to its upward trajectory. 4. **Financial Health**: The company's profitability and net margin improvements in recent quarters suggest enhanced financial health. This stability could lead to better earnings quality and a stronger market reception of the Q3 results. 5. **Industry Trends**: The broader medical equipment industry is forecasted to grow at a CAGR of 7.9%, which bodes well for Pro-Dex's future prospects. The company's growth rate is expected to outpace the industry average, indicating potential for above-average earnings in Q3. Given these factors, traders should consider a bullish stance on PDEX in the upcoming Q3 earnings report. However, it's important to monitor the company's performance closely and be prepared for any potential market reactions or adjustments based on the actual earnings figures and management's commentary.